Disease, Disability, and Injury Prevention and Control, 34751 [E8-13664]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 118 / Wednesday, June 18, 2008 / Notices
rwilkins on PROD1PC63 with NOTICES
advertisements, as well as manufacturer
specification sheets and product
brochures, would contain a power
specification obtained using an
alternative to the Rule-required testing
protocol. The Rule, however, also
requires disclosure of harmonic
distortion, power bandwidth, and
impedance ratings in manufacturer
specification sheets and product
brochures that might not otherwise be
included.
Staff assumes that manufacturers
produce one specification sheet and one
brochure each year for each new
amplifier and receiver. The burden of
disclosing the harmonic distortion,
bandwidth, and impedance information
on the specification sheets and
brochures is limited to the time needed
to draft and review the language
pertaining to the aforementioned
specifications. Staff estimates the time
involved for this task to be a maximum
of fifteen minutes for each new
specification sheet and brochure for a
total of 150 hours ([300 new products x
1 specification sheet) + (300 new
products x 1 brochure)] x 15 minutes).
The total annual burden imposed by
the Rule, therefore, is approximately
450 burden hours for testing and
disclosures.
Estimated annual cost burden:
$19,000, rounded to the nearest
thousand.2
Generally, electronics engineers
perform the testing of amplifiers and
receivers. Staff estimates a labor cost of
$12,300 for such testing (300 hours for
testing x $41 per hour). Staff assumes
advertising or promotions managers
prepare the disclosures contained in
product brochures and manufacturer
specification sheet and estimates a labor
cost of $6,600 (150 hours for disclosures
x $44 per hour). Accordingly, staff
estimates the total labor costs associated
with the Rule to be approximately
$19,000 per year, rounded to the nearest
thousand ($12,300 for testing + $6,600
for disclosures).
The Rule imposes no capital or other
non-labor costs because its requirements
are incidental to testing and advertising
done in the ordinary course of business.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Elimination of
Health Disparities Through Translation
Research (Panel A), Funding
Opportunity Announcement (FOA),
CD08–001
Special Emphasis Panel (SEP):
Epidemiological Studies of
Reproductive and Developmental
Outcomes in Denmark: Supplement on
Congenital Cytomegalovirus Infection
among Children with Hearing Loss,
Program Announcement Number (PA)
DD 07–001
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 8 a.m.–5 p.m., July 2, 2008
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Epidemiological Studies of
Reproductive and Developmental Outcomes
in Denmark: Supplement on Congenital
Cytomegalovirus Infection among Children
with Hearing Loss, PA DD 07–001.’’
Contact Person for More Information:
K. Ann Berry, Senior Scientist, CDC, 1600
Clifton Road, NE., Mailstop E20, Atlanta, GA
30333, Telephone (404) 498–2503.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: June 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–13664 Filed 6–17–08; 8:45 am]
BILLING CODE 4163–18–P
David C. Shonka
Acting General Counsel
[FR Doc. E8–13660 Filed 6–17–08: 8:45 am]
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 9 a.m.–5:30 p.m.,
July 9, 2008 (Closed); 9 a.m.–1 p.m., July
10, 2008 (Closed).
Place: Hyatt Regency Atlanta, 265
Peachtree Street, NE., Atlanta GA 30303.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Elimination of Health
Disparities through Translation
Research (Panel A), FOA CD08–001.’’
Contact Person for More Information:
Maurine F. Goodman, M.A., M.P.H.,
Scientific Review Administrator, CDC,
1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone (404)
639–4737.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: June 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–13702 Filed 6–17–08; 8:45 am]
BILLING CODE 4163–18–P
[Billing code: 6750–01–S]
2 Staff’s labor cost estimates are based on recent
data from the Bureau of Labor and Statistics.
VerDate Aug<31>2005
18:01 Jun 17, 2008
Jkt 214001
34751
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 73, Number 118 (Wednesday, June 18, 2008)]
[Notices]
[Page 34751]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13664]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Epidemiological Studies of
Reproductive and Developmental Outcomes in Denmark: Supplement on
Congenital Cytomegalovirus Infection among Children with Hearing Loss,
Program Announcement Number (PA) DD 07-001
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 8 a.m.-5 p.m., July 2, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
``Epidemiological Studies of Reproductive and Developmental Outcomes
in Denmark: Supplement on Congenital Cytomegalovirus Infection among
Children with Hearing Loss, PA DD 07-001.''
Contact Person for More Information: K. Ann Berry, Senior
Scientist, CDC, 1600 Clifton Road, NE., Mailstop E20, Atlanta, GA
30333, Telephone (404) 498-2503.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: June 11, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-13664 Filed 6-17-08; 8:45 am]
BILLING CODE 4163-18-P
